KevMed has entered into a collaboration agreement to distribute NanoVibronix's low-frequency ultrasound device in the US.
The FDA-cleared PainShield is a wearable therapeutic device and features a disposable patch connected to a portable reusable driver, which transmits ultrasound waves to the desired area of the body and alleviates pelvic pain in patients with chronic and difficult to treat symptoms.
KevMed president David Wiseman said in a clinical study, the company has found that the PainShield ultrasound therapy has reduced pain in complex abdominal and pelvic pain syndrome (CAPPS) patients.
"An abstract with clinical data reflecting this positive finding was accepted for presentation at the upcoming meeting of the International Pelvic Pain Society (IPPS) 2012 in Chicago," Wiseman added.
"I feel that for the first time, we have a real chance to revolutionize the management of pain in these patients without the risks of surgery or drugs."
NanoVibronix marketing VP Amir Rippel said PainShield can help pelvic pain patients overcome their daily suffering and return to a more normal life.
"Following our ongoing success in relieving pain for patients with trigeminal neuralgia, an extremely painful neurological facial syndrome, we believe we can reduce the suffering and improve quality of life for many other patients with specific, but difficult to treat pain," Rippel added.